Início › Colite ulcerativa › Louisiana

Ensaios clínicos de Colite ulcerativa em Louisiana

15 estudos para Colite ulcerativa estão buscando participantes em locais em Louisiana.

Cidades em Louisiana

Texto oficial do estudo (Inglês)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Gastro Group and Endocenter: Mandeville, la /ID# 284186, Mandeville
Metropolitan Gastroenterology Associates - Metairie /ID# 283922, Metairie
Willis-Knighton Medical Center /ID# 280572, Shreveport

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Baton Rouge General Medical Center - Bluebonnet Campus, Baton Rouge
Combined Gastro LLC, Lafayette
GI Alliance, Metairie

RecrutandoFase 4

Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06581328

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Clinical Trials Management, LLC, Metairie

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Site 035, Marrero

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Site US-008, Baton Rouge
Site US-011, Mandeville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07463183

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Delta Research Partners, LLC, West Monroe

RecrutandoFase 3

Idades 12 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Care Access - New Iberia, New Iberia
Louisiana Research Center, Shreveport

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

GI Alliance - Gastro Group and Endocenter - Mandeville, Mandeville

RecrutandoFase 2

Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

GI Alliance, Metairie
Tulane University, New Orleans

RecrutandoFase 4

Idades de 18 a 65 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128, Mandeville
Delta Research Partners - Site Number: 8400087, Monroe

RecrutandoFase 3

Idades de 16 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Gastroenterology Clinic of Acadiana, Lafayette

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
Tandem Intermediate, LLC - Houma -Site Number: 8400034, Houma
GastroGroup - Site Number: 8400128, Mandeville
e mais 4

RecrutandoFase 3

Idades de 16 a 80 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07184996

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Lafayette
Mirador Therapeutics Selected Site, Marrero
Mirador Therapeutics Selected Site, Shreveport

RecrutandoFase 2

Idades de 18 a 80 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT07113522

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Tulane University, New Orleans

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2025 · NCT06750731

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.